Separation Technology Creamatocrit Plus, Catalog Number: 100-146 — FDA record Z-0905-2022

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Mar 16, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Separation Technology Creamatocrit Plus, Catalog Number: 100-146
Reason
The device was being marketed as an IVD without a 510(k). Therefore, performance characteristics of these breast milk analyzers have not been adequately validated. An erroneous result could lead to sub-optimal nutrition supplementation for patients (infants)
Classification
Class II
Recalling firm
Stanbio Laboratory, LP
Quantity
50
Agency-reported status
Terminated
Source record identifier
Z-0905-2022

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilitySold between 2019 and 2021

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

US Nationwide Distribution CA, TX, OK, SD, IL, NV, MO, FL, WA, KY, WI, PA, NC, GA, MD, MN

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Apr 20, 2022
Recall initiation date
Mar 16, 2022
Center classification date
Apr 11, 2022
Termination date
Jan 2, 2025

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records